Description
This nasal spray formulation combines PT-141 (Bremelanotide) and Oxytocin, two compounds referenced in central nervous system and social-bonding research literature, in a single spray (5mg/10mg) for combined-pathway research protocols. PT-141 has been studied for melanocortin receptor pathways related to sexual response, while Oxytocin has been studied for its role in bonding and social behavior research models. Manufactured in the USA under controlled laboratory conditions, this product is intended strictly for laboratory research use. It is not a drug, dietary supplement, or cosmetic, and is not intended for human or animal consumption, diagnostic, or therapeutic use. Product handling should be restricted to qualified professionals in a controlled research setting.
Reviews
There are no reviews yet.